Close



Apr 2, 2024 08:00AM
Apr 1, 2024 04:05PM
Mar 21, 2024 08:00AM
Feb 26, 2024 10:39AM
Jan 30, 2024 04:05PM
Jan 11, 2024 08:30AM
Dec 19, 2023 08:30AM BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Dec 14, 2023 08:30AM
Dec 13, 2023 08:30AM
Nov 13, 2023 05:17PM
Nov 8, 2023 08:30AM
Nov 3, 2023 08:30AM
Sep 26, 2023 08:30AM
Sep 14, 2023 08:01AM NovaBay Pharma (NBY) Announces Commercial Launch of Avenova Allograft
Sep 14, 2023 08:00AM
Sep 11, 2023 08:03AM
Sep 11, 2023 08:00AM
Mar 23, 2023 07:30AM
Mar 7, 2023 07:30AM
Feb 14, 2023 08:55AM
Feb 1, 2023 07:30AM BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
Jan 24, 2023 07:30AM
Dec 16, 2022 07:30AM
Dec 14, 2022 07:30AM
Nov 15, 2022 04:05PM
Nov 15, 2022 07:30AM
Oct 26, 2022 07:30AM
Oct 10, 2022 07:30AM BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
Sep 13, 2022 07:30AM
Sep 8, 2022 07:30AM
Aug 22, 2022 04:01PM
Aug 16, 2022 07:30AM
Jun 17, 2022 09:25AM
Jul 27, 2021 09:00AM
May 24, 2021 11:34AM BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports
Apr 5, 2021 09:00AM
Mar 25, 2021 09:00AM
Mar 15, 2021 09:00AM
Oct 27, 2020 09:00AM
Mar 13, 2020 09:30AM
Dec 10, 2018 11:48AM
Sep 17, 2018 10:43AM Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy
Aug 28, 2018 10:10AM
Aug 9, 2018 09:00AM
Jul 19, 2018 09:00AM
Mar 26, 2018 07:22PM
Mar 24, 2017 02:18PM

251,015 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All